Value Sense
CMPS
COMPASS Pathways plc (CMPS)
Last Price$3.7(6.6%)
Market Cap$253.4M
LTM Diluted EPS
($2.2)
YoY Growth
-15.1%
3Y CAGR
+9.2%
5Y CAGR
+13.1%
Stock quality & Intrinsic value
5/10
30.5% overvalued
CMPS
is (30.5%) overvalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

COMPASS Pathways plc Diluted EPS

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Diluted EPS
($0.0)
($0.9)
($1.7)
($1.8)
($2.2)
($2.3)
CMPS
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for CMPS and see if it's the right time to invest.
Dive in

COMPASS Pathways plc (CMPS) Diluted EPS comparison analysis

General

LTM Diluted EPS

Growth

Company name

YoY growth

3Y CAGR

5Y CAGR

COMPASS Pathways plc logo
COMPASS Pathways plcCMPS
($2.2)
(15.1%)
9.2%
13.1%
Median Peer Set
$4.8
13.7%
6.1%
6.4%
Tenet Healthcare Corporation logo
Tenet Healthcare CorporationTHC
$28.9
297.7%
50.9%
N/A
HCA Healthcare, Inc. logo
HCA Healthcare, Inc.HCA
$22.0
15.8%
1.1%
16.9%
Chemed Corporation logo
Chemed CorporationCHE
$20.0
11.6%
5.8%
8.5%
DaVita Inc. logo
DaVita Inc.DVA
$10.7
33.4%
6.3%
14.7%
The Ensign Group, Inc. logo
The Ensign Group, Inc.ENSG
$5.1
39.6%
14.3%
21.0%
Encompass Health Corporation logo
Encompass Health CorporationEHC
$4.5
28.5%
2.8%
4.3%
Acadia Healthcare Company, Inc. logo
Acadia Healthcare Company, Inc.ACHC
$2.8
N/A
9.7%
17.4%
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
$1.2
(17.0%)
16.4%
N/A
Fresenius Medical Care AG & Co. KGaA logo
Fresenius Medical Care AG & Co. KGaAFMS
$1.1
(47.0%)
(16.0%)
(12.9%)
Universal Health Services, Inc. logo
Universal Health Services, Inc.UHS
($0.0)
N/A
N/A
N/A

CMPS key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Revenue
% growth
0.0
0.0%
0.0
0.0%
0.0
0.0%
0.0
0.0%
0.0
0.0%
0.0
0.0%
Cost of Goods Sold (COGS)0.00.10.10.20.30.2
Gross Profit
% margin
0.0
0.0%
(0.1)
0.0%
(0.1)
0.0%
(0.2)
0.0%
(0.3)
0.0%
(0.2)
0.0%
Operating Expenses10.518.547.173.696.0136.9
Research & Development Expenses (R&D)8.912.623.444.065.187.5
Selling, General & Administrative Expenses (SG&A)3.68.628.039.245.449.4
Operating Income
% margin
(12.5)
0.0%
(21.2)
0.0%
(51.4)
0.0%
(83.2)
0.0%
(110.4)
0.0%
(136.9)
0.0%
Interest Income0.00.00.00.00.00.0
Interest Expense0.00.00.00.00.02.2
Pre-tax Income(13.2)(19.6)(60.3)(71.5)(91.1)(117.7)
Income Tax
% effective tax rate
(0.7)
5.4%
0.0
(0.1%)
0.0
(0.1%)
0.2
(0.3%)
0.4
(0.4%)
0.8
(0.7%)
Net Income
% margin
(13.2)
0.0%
(19.6)
0.0%
(60.3)
0.0%
(71.7)
0.0%
(91.5)
0.0%
(118.5)
0.0%
EPS(0.00)(0.90)(1.68)(1.79)(2.16)(2.32)
Diluted EPS(0.00)(0.90)(1.68)(1.79)(2.16)(2.32)
EBITDA
% margin
(10.5)
0.0%
(18.4)
0.0%
(47.0)
0.0%
(83.2)
0.0%
(110.4)
0.0%
(123.8)
0.0%

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
More ideas -->

FAQ

1) What is COMPASS Pathways plc's Diluted EPS?

As of today, COMPASS Pathways plc's last 12-month Diluted EPS is ($2.2), based on the financial report for Sep 30, 2024 (Q3’2024).

2) What is COMPASS Pathways plc's Diluted EPS growth rate?

Over the last year, COMPASS Pathways plc's Diluted EPS growth was (15.1%). The average annual Diluted EPS growth rates for COMPASS Pathways plc have been (6.0%) over the past three years, 13.1% over the past five years.

3) Is COMPASS Pathways plc's Diluted EPS growth rate Good?

Over the last year, COMPASS Pathways plc's Diluted EPS growth was (15.1%), which is lower than industry growth of 0.5%. It indicates that COMPASS Pathways plc's Diluted EPS growth is Bad.

4) How does COMPASS Pathways plc's Diluted EPS growth rate compare to its peers?

Over the last year, COMPASS Pathways plc's Diluted EPS growth was (15.1%), which is lower than peer median growth of (12.4%). The list of peers includes THC, HCA, CHE, DVA, ENSG, EHC, ACHC, OPCH, FMS, UHS etc.